Status:
NOT_YET_RECRUITING
Resilience Among Individuals With Opioid Use Disorder
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to develop a human laboratory model of resilience in people with opioid use disorder (OUD). The investigators aim to learn if objective tasks that measure cognitive,...
Detailed Description
This study is an outpatient, within-subject, randomized controlled trial designed to develop and validate a novel laboratory-based model for assessing resilience in individuals with opioid use disorde...
Eligibility Criteria
Inclusion
- Can provide informed consent and can comply with study procedures
- Adults aged ≥18 years
- Meet Diagnostic and Statistical Manual (DSM-5) criteria for current opioid use disorder or are currently receiving pharmacotherapy for the treatment of OUD (e.g. methadone or buprenorphine maintenance treatment \[remission\])
- Urine sample that tests positive for opioids
- Test negative for pregnancy at screening (females only)
Exclusion
- Being pregnant or breastfeeding
- Significant mental health or physical disorder, or life circumstances, that is judged by the investigators to interfere with study participation
Key Trial Info
Start Date :
April 30 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2029
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT06954402
Start Date
April 30 2026
End Date
April 30 2029
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University Bayview Medical Campus
Baltimore, Maryland, United States, 21224